Infant Phototherapy Device Market Statistics – 2030
The global infant phototherapy device market was valued at $91,930.50 thousands in 2020, and is projected to reach $1,32,077.53 thousands by 2030, registering a CAGR of 3.7% from 2021 to 2030. Infant phototherapy Device market is expected to exhibit significant growth during the forecast period, owing to technological advancements in the field of infant phototherapy. The key factors driving the growth of market include rise in prevalence of neonatal jaundice and effectiveness of phototherapy over other treatment methods. However, side effects of phototherapy treatment is expected to hinder the market growth. Conversely, huge market potential in developing countries provide lucrative opportunities for market growth during the forecast period.
Phototherapy is one of the most effective and easy methods to treat infants suffering from neonatal jaundice. It is commonly used to reduce the bilirubin (the compound that leads to jaundice) levels in infants. During phototherapy, an infant is kept in a plastic crib, and is exposed to a type of light that is absorbed by the skin. During this process, the bilirubin in the infant's body is converted into a much simpler water-soluble form, which can be easily excreted through stool and urine. The use of phototherapy eliminates certain side effects, including mild allergic reactions, fever due to infection, and changes in blood composition, as the procedure involves exposure of the infant's body to special lights that help change bilirubin into a form that can be easily excreted out through urine.
The infant phototherapy device market is segmented on the basis of light source, configuration, end user, and region. According to light source, the market is segmented into fluorescent lamps, light-emitting diodes (LEDs), quartz halogen lamps, and gas discharge tubes. On the basis of configuration, the market is divided into mobile device and fixed device. Depending on end user, market is bifurcated into hospitals and neonatal clinics. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Covid-19 Impact
Coronavirus (COVID-19) was discovered in December 2019 in Hubei province of Wuhan city in China. The disease is caused by a virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted among humans.
Following its discovery in Wuhan, the disease rapidly spread to other parts of the globe. Moreover, this virus causes various symptoms in patients, ranging from common to serious symptoms. For instance, common symptoms include fever, dry cough, and fatigue and serious symptoms include difficulty in breathing or shortness of breath, chest pain or pressure, and loss of speech or movement. Furthermore, the virus has high potential of lethality in geriatric population. On March 11, 2020, the World Health Organization declared it as pandemic. In addition, only a few vaccines have received emergency approvals for COVID-19 prevention. Thus, social distancing is observed as the most important measure to limit the spread of this disease. Furthermore, to maintain social distancing, various countries across the globe have adopted nationwide lockdowns.
The overall impact of COVID-19 on the infant phototherapy device market is negative, owing to decline in number of birth rate and decline in number of visits of baby suufering from jaundice, as these patients are more vulnerable to COVID-19 infection, which declined the demand for infant phototherapy device products.
By Product
Fluorescent lamp segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.
Light Source Segment Review
By light source type, the infant phototherapy device market is fragmented into fluorescent lamps, light-emitting diodes (LEDs), quartz halogen lamps, and gas discharge tubes. The fluorescent lamps segment was the major revenue contributor in 2020, and is anticipated to continue this trend during the forecast period, as fluorescent lamps exhibit the most effective property of break-down of bilirubin into simple forms. However, the demand for quartz halogen lamps is projected to exhibit the fastest market growth during the forecast period, owing to rise in use of quartz halogen lamps.
By Configuration
Mobile Device segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.
Configuration Segment Review
Depending on configuration, the infant phototherapy device market is classified as mobile device and fixed device. The mobile device segment dominates the market, and is expected to remain dominant during the forecast period. This segment is expected to exhibit a prominent growth rate, owing to the fact that mobile device provides accurate estimates of accurate estimates of total serum bilirubin (TSB) values, demonstrating an inexpensive technology that uses commodity smartphones to effectively screen newborns for jaundice.
By End User
Hospital segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.
End-user Segment Review
According to end user, the hospital segment dominates the market, and is expected to remain dominant during the forecast period, owing to increase in number of jaundice treatment performed at hospitals. Implementation of government initiatives to improve the healthcare infrastructure and expanding the middle-class population in developing nations such as India result in increasing demand for quality healthcare services delivered by hospitals, thereby aiding segment growth.
By Region
North America holds a dominant position in 2020 and continue to maintain lead in the forecast year
Region Segment Review
Region wise, the infant phototherapy device market is analyzed across North America, Asia-Pacific, Europe, and LAMEA. North America dominated the market in 2020, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period. The research activities for infant phototherapy device are soaring in North America due to significant infrastructure for developmental research, availability of substantial research funds, and implementation of government initiatives toward infant phototherapy device drive the market.
This report provides comprehensive competitive analysis and profiles of prominent market players operating in Atom Medical Corporation, AVI Healthcare Pvt. Ltd., Equalize Health, Inc., General Electric Company, Ibis Medical Equipment & Systems Pvt. Ltd., Natus Medical Incorporated, Ningbo David Medical Device Co., LTD., Novos Medical Devices San. Tic. Imp & Ihr. Ltd. Sti., Weyer GmbH, Zhengzhou Dison Instrument, and Meter Co., Ltd.
Key Benefits For Stakeholders
- The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
- Analysis by light source helps understand the various types of light sources used in infant phototherapy devices.
- Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
- Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market
Infant Phototherapy Device Market Report Highlights
| Aspects | Details |
 By Light Source |
|
 By Configuration |
|
 By End User |
|
 By Region |
|
 By Key Market Players |
|
Analyst Review
Infant phototherapy device is used for the treatment of neonatal jaundice. Major components of the device include a crib and a light source along with several other accessory components. The newborn is placed in the crib, and the body is exposed to the light generated by the light source for treatment.
According to the CXOs of key companies, the adoption of infant phototherapy devices is expected to increase in the future, owing to rise in prevalence of neonatal jaundice, especially in developing regions.
Moreover, the effectiveness of phototherapy over other treatment methods drives the growth of the market. Infant phototherapy devices have gained interest of healthcare providers due to technological advancements, which have enhanced the proficiency of these devices. This has led to increase in their adoption, which, in turn, drives the market growth.
As per the perspective of CXOs, North America is expected to dominate the global infant phototherapy devices market during the forecast period, followed by Europe. In addition, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to the key players during the forecast period.
The total market value of Infant Phototherapy Device Market is $1,32,077.53 thousands in 2030
The forecast period in the report is from 2021 to 2030
The market value of Infant Phototherapy Device in 2020 was $91,930.50 thousands in 2020
The base year for the report is 2020
Yes, Infant Phototherapy Device Market companies are profiled in the report
The top companies that hold the market share in Infant Phototherapy Device Market are Atom Medical Corporation, AVI Healthcare Pvt. Ltd. Equalize Health Inc., General Electric Company, Ibis Medical Equipment & Systems Pvt. Ltd.,
No, there is no value chain analysis provided in the Infant Phototherapy Device Market report
The key trends in the Infant Phototherapy Device Market are increase in effectiveness of phototherapy over other treatment methods and rise in number of patients suffering from neonatal jaundice are expected
Loading Table Of Content...
